Summary of Purpose
The purpose of this study is to evaluate whether the serum apoB48 level is associated with atherosclerotic ischemic stroke.Read More →
The following dates are available for this trial. Trial information last updated on 4 October 2011.
|1 May 2010||21 Oct 2010||1 Mar 2011||1 Oct 2011||1 Nov 2010||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Case Control
- Perspective: Prospective
- Sampling: Probability Sample